name,category,termsG protein-coupled receptor kinase 5,INTERPRO[450000207$IPR000239:GPCR kinase, 450000294$IPR000342:Regulator of G protein signalling, 450000618$IPR000719:Protein kinase, core, 450000836$IPR000961:AGC-kinase, C-terminal, 450002035$IPR002290:Serine/threonine protein kinase, 450007563$IPR008271:Serine/threonine protein kinase, active site, 450015769$IPR017441:Protein kinase, ATP binding site, 450015770$IPR017442:Serine/threonine protein kinase-related]
G protein-coupled receptor kinase 5,KEGG_PATHWAY[470038831$hsa04062:Chemokine signaling pathway, 470038841$hsa04144:Endocytosis]
G protein-coupled receptor kinase 5,SMART[760000115$SM00133:S_TK_X, 760000193$SM00220:S_TKc, 760000285$SM00315:RGS]
G protein-coupled receptor kinase 5,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000825$kinase, 790001063$nucleotide-binding, 790001162$phosphoprotein, 790001212$polymorphism, 790001388$serine/threonine-protein kinase, 790001547$transferase]
G protein-coupled receptor kinase 5,UP_SEQ_FEATURE[850000114$active site:Proton acceptor, 850000242$binding site:ATP, 850020254$chain:G protein-coupled receptor kinase 5, 850103028$domain:AGC-kinase C-terminal, 850105086$domain:Protein kinase, 850105178$domain:RGS, 850106258$modified residue, 850106263$nucleotide phosphate-binding region:ATP, 850113517$region of interest:N-terminal, 850117295$sequence variant]
G-protein signaling modulator 2 (AGS3-like, C. elegans),INTERPRO[450001282$IPR001440:Tetratricopeptide TPR-1, 450002733$IPR003109:GoLoco motif, 450010815$IPR011990:Tetratricopeptide-like helical, 450011693$IPR013026:Tetratricopeptide region, 450017972$IPR019734:Tetratricopeptide repeat]
G-protein signaling modulator 2 (AGS3-like, C. elegans),SMART[760000020$SM00028:TPR, 760000342$SM00390:GoLoco]
G-protein signaling modulator 2 (AGS3-like, C. elegans),SP_PIR_KEYWORDS[790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001304$repeat, 790001537$tpr repeat]
G-protein signaling modulator 2 (AGS3-like, C. elegans),UP_SEQ_FEATURE[850020318$chain:G-protein-signaling modulator 2, 850104071$domain:GoLoco 1, 850104072$domain:GoLoco 2, 850104073$domain:GoLoco 3, 850104074$domain:GoLoco 4, 850106258$modified residue, 850117119$repeat:TPR 1, 850117131$repeat:TPR 2, 850117141$repeat:TPR 3, 850117142$repeat:TPR 4, 850117143$repeat:TPR 5, 850117144$repeat:TPR 6, 850117145$repeat:TPR 7, 850117146$repeat:TPR 8, 850117294$sequence conflict]
RasGEF domain family, member 1A,INTERPRO[450000558$IPR000651:Guanine nucleotide exchange factor for Ras-like GTPases, N-terminal, 450001677$IPR001895:Guanine-nucleotide dissociation stimulator CDC25, 450008163$IPR008937:Ras guanine nucleotide exchange factor, 450018036$IPR019804:Ras guanine-nucleotide exchange factor, conserved site]
RasGEF domain family, member 1A,PIR_SUPERFAMILY[630030011$PIRSF038483:RasGEF domain containing protein]
RasGEF domain family, member 1A,SMART[760000129$SM00147:RasGEF, 760000201$SM00229:RasGEFN]
RasGEF domain family, member 1A,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000641$guanine-nucleotide releasing factor]
RasGEF domain family, member 1A,UP_SEQ_FEATURE[850056711$chain:Ras-GEF domain-containing family member 1A, 850104821$domain:N-terminal Ras-GEF, 850105149$domain:Ras-GEF, 850117294$sequence conflict, 850118574$splice variant]
SH2 domain containing 5,INTERPRO[450000852$IPR000980:SH2 motif, 450005462$IPR006020:Phosphotyrosine interaction region, 450010818$IPR011993:Pleckstrin homology-type]
SH2 domain containing 5,SMART[760000224$SM00252:SH2, 760000407$SM00462:PTB]
SH2 domain containing 5,SP_PIR_KEYWORDS[790000356$complete proteome, 790001162$phosphoprotein, 790001397$SH2 domain]
SH2 domain containing 5,UP_SEQ_FEATURE[850060516$chain:SH2 domain-containing protein 5, 850105346$domain:SH2, 850106258$modified residue]
SH2 domain containing 7,INTERPRO[450000852$IPR000980:SH2 motif]
SH2 domain containing 7,SMART[760000224$SM00252:SH2]
SH2 domain containing 7,SP_PIR_KEYWORDS[790000356$complete proteome, 790001212$polymorphism, 790001397$SH2 domain]
SH2 domain containing 7,UP_SEQ_FEATURE[850060518$chain:SH2 domain-containing protein 7, 850105346$domain:SH2, 850117295$sequence variant]
amnionless homolog (mouse),INTERPRO[450000878$IPR001007:von Willebrand factor, type C]
amnionless homolog (mouse),OMIM_DISEASE[520003121$Megaloblastic anemia-1, Norwegian type]
amnionless homolog (mouse),SMART[760000187$SM00214:VWC]
amnionless homolog (mouse),SP_PIR_KEYWORDS[790000052$alternative promoter usage, 790000356$complete proteome, 790000428$developmental protein, 790000445$direct protein sequencing, 790000446$disease mutation, 790000616$glycoprotein, 790000919$membrane, 790001405$signal, 790001555$transmembrane]
amnionless homolog (mouse),UP_SEQ_FEATURE[850045038$chain:Protein amnionless, 850105643$domain:VWFC, 850105770$glycosylation site:N-linked (GlcNAc...), 850117295$sequence variant, 850117814$signal peptide, 850118577$topological domain:Cytoplasmic, 850118583$topological domain:Extracellular, 850118623$transmembrane region]
ankyrin repeat and BTB (POZ) domain containing 2,INTERPRO[450000181$IPR000210:BTB/POZ-like, 450001870$IPR002110:Ankyrin, 450008207$IPR009072:Histone-fold, 450010229$IPR011333:BTB/POZ fold, 450011722$IPR013069:BTB/POZ, 450011733$IPR013089:Kelch related]
ankyrin repeat and BTB (POZ) domain containing 2,PIR_SUPERFAMILY[630029983$PIRSF038450:ankyrin repeat and BTB/POZ domain protein, ABTB2 type]
ankyrin repeat and BTB (POZ) domain containing 2,SMART[760000197$SM00225:BTB, 760000220$SM00248:ANK]
ankyrin repeat and BTB (POZ) domain containing 2,SP_PIR_KEYWORDS[790000086$ank repeat, 790000356$complete proteome, 790001212$polymorphism, 790001304$repeat]
ankyrin repeat and BTB (POZ) domain containing 2,UP_SEQ_FEATURE[850005318$chain:Ankyrin repeat and BTB/POZ domain- containing protein 2, 850103177$domain:BTB, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850115655$repeat:ANK 4, 850117295$sequence variant]
bridging integrator 2,INTERPRO[450002641$IPR003005:Amphiphysin, 450003659$IPR004148:BAR]
bridging integrator 2,SMART[760000627$SM00721:BAR]
bridging integrator 2,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000344$coiled coil, 790000356$complete proteome, 790000407$cytoplasm, 790001162$phosphoprotein, 790001212$polymorphism]
bridging integrator 2,UP_SEQ_FEATURE[850008397$chain:Bridging integrator 2, 850102581$compositionally biased region:Poly-Ser, 850102586$compositionally biased region:Pro-rich, 850103092$domain:BAR, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant]
calmodulin binding transcription activator 1,INTERPRO[450000040$IPR000048:IQ calmodulin-binding region, 450001870$IPR002110:Ankyrin, 450002569$IPR002909:Cell surface receptor IPT/TIG, 450005011$IPR005559:CG-1]
calmodulin binding transcription activator 1,SMART[760000009$SM00015:IQ, 760000220$SM00248:ANK, 760000375$SM00429:IPT]
calmodulin binding transcription activator 1,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000086$ank repeat, 790000356$complete proteome, 790000407$cytoplasm, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation]
calmodulin binding transcription activator 1,UP_SEQ_FEATURE[850009135$chain:Calmodulin-binding transcription activator 1, 850102573$compositionally biased region:Poly-Gly, 850102585$compositionally biased region:Poly-Val, 850102903$DNA-binding region:CG-1, 850104420$domain:IPT/TIG, 850104440$domain:IQ 1, 850104451$domain:IQ 2, 850104462$domain:IQ 3, 850106258$modified residue, 850115632$repeat:ANK 1, 850115644$repeat:ANK 2, 850115654$repeat:ANK 3, 850117295$sequence variant, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118575$strand]
chemokine (C-C motif) ligand 13,BBID[10000012$109.Chemokine_families]
chemokine (C-C motif) ligand 13,INTERPRO[450000719$IPR000827:Small chemokine, C-C group, conserved site, 450001604$IPR001811:Small chemokine, interleukin-8-like]
chemokine (C-C motif) ligand 13,KEGG_PATHWAY[470038830$hsa04060:Cytokine-cytokine receptor interaction, 470038831$hsa04062:Chemokine signaling pathway, 470038863$hsa04621:NOD-like receptor signaling pathway]
chemokine (C-C motif) ligand 13,PIR_SUPERFAMILY[630002087$PIRSF001950:small inducible chemokine, C/CC types, 630030769$PIRSF500572:small inducible cytokine, A2 type]
chemokine (C-C motif) ligand 13,SMART[760000172$SM00199:SCY]
chemokine (C-C motif) ligand 13,SP_PIR_KEYWORDS[790000002$3d-structure, 790000291$chemotaxis, 790000356$complete proteome, 790000402$cytokine, 790000445$direct protein sequencing, 790000447$disulfide bond, 790000775$inflammatory response, 790001212$polymorphism, 790001291$Pyrrolidone carboxylic acid, 790001363$Secreted, 790001405$signal]
chemokine (C-C motif) ligand 13,UP_SEQ_FEATURE[850008601$chain:C-C motif chemokine 13, long chain, 850008602$chain:C-C motif chemokine 13, medium chain, 850008603$chain:C-C motif chemokine 13, short chain, 850102883$disulfide bond, 850105852$helix, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850117814$signal peptide, 850118575$strand]
chromosome 10 open reading frame 119,INTERPRO[450017386$IPR019140:Protein of unknown function DUF2044, membrane]
chromosome 10 open reading frame 119,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790001162$phosphoprotein]
chromosome 10 open reading frame 119,UP_SEQ_FEATURE[850097744$chain:UPF0557 protein C10orf119, 850106258$modified residue, 850117294$sequence conflict, 850118574$splice variant]
chromosome 12 open reading frame 68,SP_PIR_KEYWORDS[790000344$coiled coil, 790000356$complete proteome, 790001212$polymorphism]
chromosome 12 open reading frame 68,UP_SEQ_FEATURE[850073076$chain:Uncharacterized protein C12orf68, 850102572$compositionally biased region:Poly-Glu, 850117294$sequence conflict, 850117295$sequence variant]
chromosome 18 open reading frame 45,COG_ONTOLOGY[90000022$Carbohydrate transport and metabolism / Posttranslational modification, protein turnover, chaperones / Intracellular trafficking and secretion]
chromosome 18 open reading frame 45,OMIM_DISEASE[520003072$Many sequence variants affecting diversity of adult human height]
chromosome 18 open reading frame 45,SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000919$membrane, 790001212$polymorphism, 790001555$transmembrane]
chromosome 18 open reading frame 45,UP_SEQ_FEATURE[850066266$chain:Transmembrane protein C18orf45, 850117295$sequence variant, 850118574$splice variant, 850118623$transmembrane region]
iron-sulfur cluster scaffold homolog (E. coli),INTERPRO[450002538$IPR002871:NIF system FeS cluster assembly, NifU, N-terminal, 450010234$IPR011339:ISC system FeS cluster assembly, IscU scaffold]
iron-sulfur cluster scaffold homolog (E. coli),OMIM_DISEASE[520003486$Myopathy with exercise intolerance, Swedish type]
iron-sulfur cluster scaffold homolog (E. coli),PIR_SUPERFAMILY[630000436$PIRSF000374:iron-sulfur cluster assembly protein, IscU type]
iron-sulfur cluster scaffold homolog (E. coli),SP_PIR_KEYWORDS[790000053$alternative splicing, 790000356$complete proteome, 790000407$cytoplasm, 790000802$iron, 790000937$metal-binding, 790000969$mitochondrion, 790001065$nucleus, 790001162$phosphoprotein, 790001212$polymorphism, 790001550$transit peptide]
iron-sulfur cluster scaffold homolog (E. coli),UP_SEQ_FEATURE[850026800$chain:Iron-sulfur cluster assembly enzyme ISCU, mitochondrial, 850106258$modified residue, 850117294$sequence conflict, 850117295$sequence variant, 850118574$splice variant, 850118617$transit peptide:Mitochondrion]
ligand dependent nuclear receptor corepressor,INTERPRO[450007237$IPR007889:Helix-turn-helix, Psq, 450010388$IPR011526:Helix-turn-helix, Psq-like]
ligand dependent nuclear receptor corepressor,SP_PIR_KEYWORDS[790000002$3d-structure, 790000020$activator, 790000053$alternative splicing, 790000356$complete proteome, 790000466$dna-binding, 790001065$nucleus, 790001162$phosphoprotein, 790001307$repressor, 790001539$Transcription, 790001543$transcription regulation]
ligand dependent nuclear receptor corepressor,UP_SEQ_FEATURE[850028553$chain:Ligand-dependent corepressor, 850102916$DNA-binding region:H-T-H motif, 850104179$domain:HTH psq-type, 850105852$helix, 850106258$modified residue, 850106259$mutagenesis site, 850117294$sequence conflict, 850117504$short sequence motif:Interaction with nuclear receptors, 850117610$short sequence motif:Nuclear localization signal, 850118574$splice variant, 850118624$turn]
potassium channel, subfamily K, member 1,INTERPRO[450001573$IPR001779:Potassium channel, two pore-domain, TWIK-1, 450002860$IPR003280:Potassium channel, two pore-domain, 450004866$IPR005408:Potassium channel, two pore-domain, TWIK, 450011743$IPR013099:Ion transport 2]
potassium channel, subfamily K, member 1,PIR_SUPERFAMILY[630029642$PIRSF038061:potassium channel, subfamily K type]
potassium channel, subfamily K, member 1,SP_PIR_KEYWORDS[790000356$complete proteome, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001162$phosphoprotein, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium channel, subfamily K, member 1,UP_SEQ_FEATURE[850040045$chain:Potassium channel subfamily K member 1, 850105770$glycosylation site:N-linked (GlcNAc...), 850106258$modified residue, 850106259$mutagenesis site, 850114080$region of interest:Pore-forming 1, 850114082$region of interest:Pore-forming 2, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
potassium voltage-gated channel, Isk-related family, member 3,INTERPRO[450004884$IPR005426:Potassium channel, voltage-dependent, beta subunit, KCNE3]
potassium voltage-gated channel, Isk-related family, member 3,OMIM_DISEASE[520002519$Hypokalemic periodic paralysis]
potassium voltage-gated channel, Isk-related family, member 3,SP_PIR_KEYWORDS[790000207$Brugada syndrome, 790000356$complete proteome, 790000446$disease mutation, 790000616$glycoprotein, 790000798$ion transport, 790000799$ionic channel, 790000919$membrane, 790001212$polymorphism, 790001226$potassium, 790001227$potassium channel, 790001229$potassium transport, 790001555$transmembrane, 790001558$transport, 790001631$voltage-gated channel]
potassium voltage-gated channel, Isk-related family, member 3,UP_SEQ_FEATURE[850040176$chain:Potassium voltage-gated channel subfamily E member 3, 850105770$glycosylation site:N-linked (GlcNAc...), 850106259$mutagenesis site, 850117295$sequence variant, 850118577$topological domain:Cytoplasmic, 850118623$transmembrane region]
transcription factor 23,INTERPRO[450000957$IPR001092:Basic helix-loop-helix dimerisation region bHLH]
transcription factor 23,SMART[760000321$SM00353:HLH]
transcription factor 23,SP_PIR_KEYWORDS[790000356$complete proteome, 790000428$developmental protein, 790000434$differentiation, 790001001$myogenesis, 790001065$nucleus, 790001212$polymorphism]
transcription factor 23,UP_SEQ_FEATURE[850064985$chain:Transcription factor 23, 850102900$DNA-binding region:Basic motif, 850104114$domain:Helix-loop-helix motif, 850117295$sequence variant]
transglutaminase 5,INTERPRO[450000965$IPR001102:Transglutaminase, N-terminal, 450002585$IPR002931:Transglutaminase-like, 450008173$IPR008957:Fibronectin, type III-like fold, 450008174$IPR008958:Transglutaminase, C-terminal, 450012396$IPR013783:Immunoglobulin-like fold, 450012414$IPR013808:Transglutaminase, conserved site]
transglutaminase 5,OMIM_DISEASE[520003946$peeling skin syndrome (PSS), 520003947$Peeling skin syndrome, acral type]
transglutaminase 5,PIR_SUPERFAMILY[630000540$PIRSF000459:protein-glutamine gamma-glutamyltransferase/erythrocyte membrane protein band 4.2, 630030611$PIRSF500382:protein-glutamine gamma-glutamyltransferase]
transglutaminase 5,SMART[760000405$SM00460:TGc]
transglutaminase 5,SP_PIR_KEYWORDS[790000012$acetylation, 790000025$Acyltransferase, 790000053$alternative splicing, 790000211$calcium, 790000356$complete proteome, 790000407$cytoplasm, 790000445$direct protein sequencing, 790000446$disease mutation, 790000937$metal-binding, 790001212$polymorphism, 790001547$transferase]
transglutaminase 5,UP_SEQ_FEATURE[850048606$chain:Protein-glutamine gamma- glutamyltransferase 5, 850105909$metal ion-binding site:Calcium, 850106258$modified residue, 850117295$sequence variant, 850118574$splice variant]
zinc finger protein 642,COG_ONTOLOGY[90000073$General function prediction only]
zinc finger protein 642,INTERPRO[450001691$IPR001909:Krueppel-associated  box, 450006475$IPR007087:Zinc finger, C2H2-type, 450011731$IPR013087:Zinc finger, C2H2-type/integrase, DNA-binding, 450014303$IPR015880:Zinc finger, C2H2-like]
zinc finger protein 642,PIR_SUPERFAMILY[630005483$PIRSF005559:zinc finger protein ZFP-36]
zinc finger protein 642,SMART[760000317$SM00349:KRAB, 760000323$SM00355:ZnF_C2H2]
zinc finger protein 642,SP_PIR_KEYWORDS[790000356$complete proteome, 790000466$dna-binding, 790000937$metal-binding, 790001065$nucleus, 790001212$polymorphism, 790001304$repeat, 790001539$Transcription, 790001543$transcription regulation, 790001648$zinc, 790001651$zinc-finger]
zinc finger protein 642,UP_SEQ_FEATURE[850101818$chain:Zinc finger protein 642, 850104552$domain:KRAB, 850105271$domain:SCAN box, 850117294$sequence conflict, 850117295$sequence variant, 850118656$zinc finger region:C2H2-type 1, 850118688$zinc finger region:C2H2-type 2, 850118711$zinc finger region:C2H2-type 3, 850118722$zinc finger region:C2H2-type 4, 850118725$zinc finger region:C2H2-type 5, 850118728$zinc finger region:C2H2-type 6, 850118731$zinc finger region:C2H2-type 7, 850118734$zinc finger region:C2H2-type 8, 850118737$zinc finger region:C2H2-type 9]
